Publications - Search Publications by Mayo Clinic Authors - Mayo Clinic Research

no_english_version

no_arabic_version

Search

Request an Appointment
Find a Doctor
Find a Job
Give Now

Log in to Patient Account
English

Twitter
Facebook
Pinterest
YouTube

English

Menu
Search

Search

All Mayo Clinic Topics

Care at Mayo Clinic
Health Information
Featured conditions
Brain tumor, breast cancer, colon cancer, congenital heart disease, heart arrhythmia. See more conditions.
For Medical Professionals
Research
College of Medicine and Science
Giving to Mayo Clinic

Request an Appointment
Find a Doctor
Find a Job
Give Now

Log in to Patient Account
English

Twitter
Facebook
Pinterest
YouTube

Search Results 981-990 of 1000 for remote monitoring

Narrow your search

Narrow your search

Year:

Results

Improving Neurosurgical Outcomes in the Intensive Care Unit: Could Dexmedetomidine Make a Difference in Ventilator Free Days, Neurological Monitoring, and Outcomes?
1. Rahme RJ, Pines AR, Welz M, Aoun RJN, Aoun RJN, Sattur MG, Krishna C, Bendok BR.
2. World Neurosurg 2016 Oct; 94:556-558 Epub 2016 July 28
ACP Journal Club. Minimally invasive and conventional glucose monitoring did not differ for long-term glycemic control in insulin-treated diabetes.
1. Muthusamy K, Smith SA, Dinneen SF, Dennedy MC.
2. Ann Intern Med. 2009 Oct 20; 151(8):JC4-6, JC4-7.
Monitoring thyroglobulin in a sensitive immunoassay has comparable sensitivity to recombinant human TSH-stimulated thyroglobulin in follow-up of thyroid cancer patients.
1. Smallridge RC, Meek SE, Morgan MA, Gates GS, Fox TP, Grebe S, Fatourechi V.
2. J Clin Endocrinol Metab. 2007 Jan; 92(1):82-7.
Author's Reply to Pestana et al. Comment on: "Is There a Role for Therapeutic Drug Monitoring in Patients with Hidradenitis Suppurativa on Tumor Necrosis Factor-a Inhibitors?".
1. Alavi A, Raffals L.
2. Am J Clin Dermatol. 2022 Jul; 23(4):593-594. Epub 2022 Jun 04.
Finger capillary blood sampling for ANC monitoring in a pilot clozapine clinic: Another option between venipuncture and emerging point-of-care technology.
1. Leung JG, Mara KC, Johnson EK, Wittenberger TS, Schak KM.
2. Schizophr Res 2023 Feb; 252:127-128 Epub 2023 Jan 13
Letter to the editor: "Reducing plastic waste in intensive care from longer use of intravenous administration and invasive monitoring sets: A before-and-after study".
1. Desai R, Manjappachar N, Nunna KR.
2. J Crit Care 2025 Aug; 88:155084 Epub 2025 Apr 19
F-18 FDG-PET for detection of osseous metastatic disease and staging, restaging, and monitoring response to therapy of musculoskeletal tumors.
1. Peterson JJ.
2. Semin Musculoskelet Radiol. 2007 Sep; 11 (3):246-60
Comparison of several von Willebrand factor (VWF) activity assays for monitoring patients undergoing treatment with VWF/FVIII concentrates: improved performance with a new modified automated method.
1. Hillarp A, Friedman KD, Adcock-Funk D, Tiefenbacher S, Nichols WL, Chen D, Stadler M, Schwartz BA.
2. Haemophilia. 2015 Nov; 21: (6)837-45.
Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring.
1. Irazabal MV, Mishra PK, Torres VE, Macura SI.
2. J Vis Exp. 2015 Jun 23; (100):e52757 Epub 2015 June 23
A decade of follow-up and therapeutic drug monitoring in HIV-2 immunocompromised patients at St Camille and General Lamizana Military Medical Centers, Burkina Faso, West Africa.
1. Sanou M, Soubeiga ST, Bationo F, Compaore TR, Zohoncon TM, Diatto GN, Ouedraogo P, Pietra V, Nagalo BM, Bisseye C, Traore RO, Simpore J.
2. Pak J Biol Sci. 2014 Dec; 17 (12):1219-24

Pagination Publications

Previous Page
Go to page 97
Go to page 98
Go to page 99
Go to page 100
Next Page

.

Mayo Clinic Footer

Request Appointment
Give Now
Contact Us
About Mayo Clinic
Employees
Site Map
About This Site

Legal Conditions and Terms

Any use of this site constitutes your agreement to the Terms and Conditions and Privacy Policy linked below.

Terms and Conditions
Privacy Policy
Notice of Privacy Practices
Notice of Nondiscrimination
Manage Cookies

Advertising

Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products and services advertised.

Advertising and sponsorship policy
Advertising and sponsorship opportunities

Reprint Permissions

A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.org," "Mayo Clinic Healthy Living," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.

© 1998-2025 Mayo Foundation for Medical Education and Research (MFMER). All rights reserved.